Why social is no longer the forgotten part of ESG

As companies have increased their focus on ESG issues over the past few years, they have tended to concentrate on the E and the G - with the S being rather left behind.

Policing a COVID-19 world

Andrew Newsham explores the presented operational challenges to policing during COVID-19 and how the profession may use this crisis as a catalyst to transform.

Can continuous manufacturing fix pharma's shortfalls?

COVID-19 has pushed the pharmaceutical sector to the forefront of public consciousness. Johnathon Marshall considers if continuous manufacturing can fix pharma's shortfalls.

Managing fund liquidity through product governance

Firms may face scrutiny on how effectively they are managing liquidity risk through their wider approach to product design and distribution.

Powered by Feed Informer